YOLFTbeta
Teva Pharma Industries Ltd ADR

Teva Pharma Industries Ltd ADR

TEVA · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic

44.50USD+0.85 (+1.95%)

Price History

Full chart

Market Stats

Previous Close43.65
Open43.91
Day Range43.43 – 44.57
52-Week Range19.98 – 42.02
Volume7.56M
Market Cap46.62B
P/E (TTM)66.62
Forward P/E13.07
EPS0.60
Dividend Yield0.00%
Beta0.82
50-Day Avg38.90
200-Day Avg34.49

About

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Richard D. Francis
  • Employees31.17K
  • Headquarters124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020, USA
  • Websitehttps://www.tevapharm.com

Leadership

  • Mr. Richard D. FrancisPresident, CEO & Director · b. 1968
  • Mr. Eliyahu Sharon KalifExecutive VP & CFO · b. 1974
  • Dr. Eric A. Hughes M.D., Ph.D.Executive VP of Global R&D and Chief Medical Officer · b. 1970
  • Ms. Christine FoxExecutive VP of US Commercial & Head of Innovative Franchise · b. 1969
  • Mr. Evan Lippman M.B.A.Executive Vice President of Business Development · b. 1970
  • Mr. Matthew ShieldsExecutive Vice President of Global Operations · b. 1975
  • Mr. Amir WeissSenior VP & Chief Accounting Officer · b. 1977
  • Mr. Christopher J. Stevo CFASenior Vice President of Investor Relations & Competitive Intelligence
  • Kathleen VeitSenior Vice President, Global Compliance & Ethics Officer
  • Mr. Brian SavageInterim Chief Legal Officer

Financials

Income Statement

Currency: USD1985-12-311986-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue91.20M139.60M211.10M281.10M329.00M327.10M406.70M502.00M587.70M667.70M953.80M1.12B1.12B1.28B1.75B2.08B2.52B3.28B4.80B5.25B8.41B9.41B11.09B13.90B16.12B18.31B20.32B20.31B20.27B19.65B21.90B22.39B18.85B16.89B16.66B15.88B14.93B15.85B16.54B17.26B
Growth (%)-+53.07%+51.22%+33.16%+17.04%-0.58%+24.34%+23.43%+17.07%+13.61%+42.85%+17.10%-0.09%+14.92%+36.45%+18.72%+21.24%+30.09%+46.47%+9.41%+60.14%+11.89%+17.83%+25.39%+15.99%+13.59%+10.95%-0.01%-0.21%-3.06%+11.45%+2.20%-15.77%-10.43%-1.35%-4.69%-6.00%+6.17%+4.40%+4.31%
Cost of Revenue58.80M84.90M129.50M180.70M191.30M194.10M229.80M268.50M305.70M364.10M550.40M628.90M636.10M699.20M962.99M1.23B1.42B1.76B2.56B2.77B4.15B4.53B5.12B6.53B7.06B8.80B9.66B9.61B9.22B8.30B10.04B11.56B10.56B9.35B8.93B8.28B7.95B8.20B8.48B8.32B
Gross Profit32.40M54.70M81.60M100.40M137.70M133.00M176.90M233.50M282.00M303.60M403.40M488.00M479.80M583.20M786.86M847.29M1.10B1.52B2.24B2.48B4.26B4.88B5.97B7.37B9.06B9.52B10.65B10.71B11.06B11.36B11.86B10.82B8.30B7.54B7.73B7.59B6.97B7.64B8.06B8.94B
Gross Margin35.53%39.18%38.65%35.72%41.85%40.66%43.50%46.51%47.98%45.47%42.29%43.69%43.00%45.48%44.97%40.79%43.49%46.36%46.66%47.25%50.65%51.84%53.84%53.00%56.23%51.96%52.43%52.71%54.54%57.79%54.14%48.36%44.00%44.63%46.38%47.83%46.72%48.25%48.74%51.79%
Operating Expense20.50M35.40M59.10M56.20M97.40M80.90M120.90M145.50M175.30M188.40M274.10M314.20M334.80M384.16M542.34M486.50M571.40M641.50M1.66B1.17B3.46B2.48B4.82B4.96B5.19B6.41B8.45B9.06B7.11B8.00B9.71B28.31B9.93B7.98B11.30B5.88B9.17B7.21B8.37B6.78B
Operating Income11.90M19.30M22.50M44.20M40.30M52.10M56.00M88.00M106.70M115.20M129.30M173.80M145.00M199.05M244.53M360.79M524.00M877.40M577.80M1.31B801.00M2.40B1.15B2.40B3.87B3.11B2.21B1.65B3.95B3.35B2.15B-17.48B-1.64B-443.00M-3.57B1.72B-2.20B433.00M-303.00M2.16B
Operating Margin13.05%13.83%10.66%15.72%12.25%15.93%13.77%17.53%18.16%17.25%13.56%15.56%12.99%15.52%13.97%17.37%20.81%26.78%12.04%25.01%9.53%25.46%10.33%17.30%24.01%16.98%10.85%8.12%19.49%17.06%9.83%-78.11%-8.68%-2.62%-21.44%10.81%-14.72%2.73%-1.83%12.50%
EBITDA15.40M24.40M30.30M44.30M52.90M65.90M72.80M107.60M134.30M137.20M173.00M225.80M262.48M335.89M470.19M485.58M524.00M1.01B1.39B1.55B2.53B2.40B1.64B2.40B4.83B4.26B3.88B3.21B5.97B6.34B2.90B-15.48B186.00M4.44B4.61B4.41B-925.00M433.00M4.43B3.14B
EBITDA Margin16.89%17.48%14.35%15.76%16.08%20.15%17.90%21.43%22.85%20.55%18.14%20.22%23.52%26.19%26.87%23.37%20.81%30.90%29.03%29.62%30.05%25.46%14.78%17.30%29.93%23.26%19.11%15.78%29.47%32.27%13.22%-69.15%0.99%26.28%27.68%27.77%-6.20%2.73%26.78%18.20%
Net Income7.60M14.80M12.00M16.90M20.80M23.70M32.60M57.50M71.60M79.80M73.40M101.50M68.80M117.83M148.42M278.21M410.30M691.00M331.80M1.07B546.00M1.95B635.00M2.00B3.33B2.76B1.96B1.27B3.06B1.59B329.00M-16.27B-2.15B-999.00M-3.99B417.00M-2.45B-559.00M-1.64B1.41B
Net Income Margin8.33%10.60%5.68%6.01%6.32%7.25%8.02%11.45%12.18%11.95%7.70%9.09%6.17%9.19%8.48%13.39%16.29%21.09%6.91%20.42%6.49%20.75%5.73%14.39%20.66%15.07%9.66%6.25%15.07%8.08%1.50%-72.66%-11.40%-5.92%-23.95%2.63%-16.39%-3.53%-9.91%8.17%
R&D--------36.60M31.60M62.80M65.20M68.10M81.84M104.58M107.27M165.00M213.50M338.40M368.90M495.00M581.00M786.00M802.00M933.00M1.09B1.36B1.43B1.49B1.52B2.11B1.85B1.21B1.01B1.79B1.09B838.00M953.00M1.05B1.01B
R&D as % of Total Revenue--------6.23%4.73%6.58%5.84%6.10%6.38%5.98%5.16%6.55%6.52%7.05%7.03%5.89%6.18%7.09%5.77%5.79%5.98%6.67%7.02%7.34%7.76%9.64%8.26%6.43%5.98%10.77%6.89%5.61%6.01%6.38%5.87%
Interest Expense5.70M9.80M2.40M25.80M8.40M14.20M2.70M500.00K5.10M7.40M46.00M42.90M67.30M44.35M193.07M43.13M16.80M80.30M1.20B4.40M2.70B112.00M318.00M230.00M225.00M153.00M355.00M282.00M276.00M465.00M1.33B895.00M881.00M957.00M755.00M891.00M930.00M1.03B941.00M916.00M
Interest Expense % of Total Revenue6.25%7.02%1.14%9.18%2.55%4.34%0.66%0.10%0.87%1.11%4.82%3.84%6.03%3.46%11.03%2.08%0.67%2.45%25.05%0.08%32.14%1.19%2.87%1.65%1.40%0.84%1.75%1.39%1.36%2.37%6.07%4.00%4.67%5.67%4.53%5.61%6.23%6.49%5.69%5.31%

Balance Sheet

Currency: USD1985-12-311986-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets139.10M142.80M248.10M286.70M343.80M376.70M445.00M562.90M676.00M871.30M1.24B1.19B1.44B1.71B2.86B3.46B4.63B5.92B9.63B10.39B20.47B23.41B32.90B33.81B39.05B50.14B50.61B47.51B46.42B54.26B92.89B70.61B60.68B57.47B50.64B47.67B44.01B43.48B39.33B40.75B
Total Liabilities89.20M85.00M149.00M167.30M208.20M193.70M221.90M295.00M333.60M463.70M706.20M575.60M776.40M971.72M1.70B2.08B2.79B2.62B4.23B4.34B9.29B9.65B16.54B14.55B17.05B27.80B27.74B24.87B23.07B24.33B57.90B51.87B44.89B42.41B39.58B36.42B35.41B35.35B33.61B32.83B
Total Equity49.90M57.80M99.10M119.40M135.60M182.40M222.30M267.50M342.00M402.90M534.20M612.00M658.80M742.28M1.15B1.38B1.83B3.29B5.39B6.04B11.14B13.72B16.30B19.22B21.95B22.20B22.77B22.57B23.31B29.77B33.34B17.36B14.71B13.97B10.03B10.28B7.80B7.51B5.37B7.91B
Cash22.40M15.90M13.10M4.60M15.40M7.90M13.80M39.90M42.40M63.40M61.20M50.90M47.10M77.18M420.63M768.92M809.90M1.06B784.10M1.28B1.33B1.49B1.85B2.00B1.25B1.10B2.88B1.04B2.23B6.95B988.00M963.00M1.78B1.98B2.18B2.17B2.80B3.23B3.30B3.56B
Total Debt39.80M35.90M74.30M91.40M124.00M115.00M133.70M178.60M219.10M291.20M502.30M369.70M526.20M667.68M1.16B1.45B1.90B1.46B2.07B2.15B5.33B5.19B8.44B6.34B5.53B14.52B14.72B12.19B10.33B9.97B35.80B32.48B28.92B27.34B26.40B23.46B21.56B20.15B18.08B17.38B
Net Debt17.40M20.00M61.20M86.80M108.60M107.10M119.90M138.70M176.70M227.80M441.10M318.80M479.10M590.50M734.78M684.48M1.09B402.30M1.29B873.20M4.00B3.70B6.59B4.34B4.28B13.42B11.84B11.15B8.10B3.02B34.81B31.51B27.13B25.37B24.22B21.29B18.76B16.93B14.78B13.83B

Cash Flow

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.10M28.20M37.70M38.20M105.40M-6.80M193.60M70.20M153.61M165.63M273.15M353.70M626.60M1.25B1.37B2.06B1.81B3.23B3.37B4.14B4.13B4.57B3.24B5.13B5.54B5.22B3.51B2.45B538.00M1.22B798.00M1.59B1.37B1.25B1.65B
Investing Cash Flow-48.30M-46.90M-56.00M-75.90M-119.00M-127.00M-65.20M-130.60M-270.42M-84.31M-190.65M-664.90M-435.10M-2.40B-537.80M-4.06B-1.35B-4.14B-916.00M-5.46B-7.60B-1.13B-1.15B-1.45B-5.57B-35.74B2.16B1.87B1.35B863.00M1.52B656.00M968.00M792.00M737.00M
Financing Cash Flow35.20M24.60M44.60M40.20M34.20M131.20M-134.50M55.20M151.48M265.71M266.72M337.50M29.60M852.40M-312.70M2.02B-362.00M1.36B-2.27B573.00M3.34B-1.68B-3.88B-2.38B4.80B25.22B-5.75B-3.35B-241.00M-1.89B-2.17B-1.49B-1.91B-1.79B-2.15B
Capital Expenditure22.30M27.30M45.30M79.50M112.60M135.30M63.40M135.60M67.07M89.42M134.07M160.40M207.50M311.00M310.10M390.00M542.00M681.00M719.00M710.00M1.05B1.10B1.03B929.00M772.00M901.00M874.00M651.00M119.00M578.00M562.00M548.00M526.00M498.00M501.00M
Free Cash Flow-13.20M900.00K-7.60M-41.30M-7.20M-142.10M130.20M-65.40M86.53M76.21M139.08M193.30M419.10M937.80M1.06B1.67B1.27B2.55B2.65B3.43B3.08B3.47B2.21B4.20B4.77B4.32B2.63B1.79B419.00M638.00M236.00M1.04B842.00M749.00M1.15B
Dividends Paid4.30M5.30M7.80M15.90M14.50M14.60M21.70M20.10M17.77M27.64M32.76M46.60M76.30M120.70M162.10M229.00M299.00M388.00M528.00M668.00M800.00M855.00M1.09B1.16B1.16B1.56B1.16B22.00M52.00M------
FCF to OCF-145.05%3.19%-20.16%-108.12%-6.83%2089.71%67.25%-93.16%56.34%46.01%50.92%54.65%66.88%75.10%77.36%81.05%70.10%78.92%78.68%82.83%74.53%75.85%68.15%81.88%86.07%82.76%75.08%73.39%77.88%52.47%29.57%65.53%61.55%60.06%69.62%
Dividend Paid to FCF-32.58%588.89%-102.63%-38.50%-201.39%-10.27%16.67%-30.73%20.53%36.27%23.56%24.11%18.21%12.87%15.29%13.73%23.52%15.22%19.89%19.50%25.97%24.65%49.37%27.54%24.21%36.03%44.09%1.23%12.41%------

Earnings

Report DateAug 6, 1995Nov 7, 1995Feb 29, 1996May 13, 1996Aug 15, 1996Nov 11, 1996Feb 24, 1997May 8, 1997Aug 4, 1997Nov 11, 1997Feb 24, 1998May 11, 1998Aug 7, 1998Nov 10, 1998May 6, 1999Jul 29, 1999Nov 1, 1999Feb 11, 2000May 4, 2000Jul 31, 2000Nov 7, 2000Apr 24, 2001Jul 26, 2001Oct 30, 2001Feb 14, 2002Apr 29, 2002Jul 28, 2002Oct 28, 2002Feb 18, 2003May 1, 2003Jul 29, 2003Nov 3, 2003Feb 17, 2004May 4, 2004Aug 3, 2004Nov 4, 2004Feb 15, 2005May 3, 2005Aug 1, 2005Nov 8, 2005Feb 28, 2006May 10, 2006Aug 8, 2006Nov 7, 2006Feb 13, 2007May 2, 2007Aug 1, 2007Oct 30, 2007Feb 12, 2008May 6, 2008Jul 29, 2008Nov 6, 2008Feb 17, 2009May 5, 2009Jul 28, 2009Nov 3, 2009Feb 16, 2010May 4, 2010Jul 27, 2010Nov 2, 2010Feb 8, 2011May 11, 2011Jul 27, 2011Nov 2, 2011Feb 15, 2012May 9, 2012Aug 2, 2012Nov 1, 2012Feb 7, 2013May 2, 2013Aug 1, 2013Oct 31, 2013Feb 6, 2014May 1, 2014Jul 31, 2014Oct 30, 2014Feb 5, 2015Apr 30, 2015Jul 30, 2015Oct 29, 2015Feb 11, 2016May 9, 2016Aug 4, 2016Nov 15, 2016Feb 13, 2017May 11, 2017Aug 3, 2017Nov 2, 2017Feb 8, 2018May 3, 2018Aug 2, 2018Nov 1, 2018Feb 13, 2019May 2, 2019Aug 7, 2019Nov 7, 2019Feb 12, 2020May 7, 2020Aug 5, 2020Nov 5, 2020Feb 10, 2021Apr 28, 2021Jul 28, 2021Oct 27, 2021Feb 9, 2022May 3, 2022Jul 26, 2022Nov 3, 2022Feb 8, 2023May 10, 2023Aug 2, 2023Nov 8, 2023Jan 31, 2024May 8, 2024Jul 31, 2024Nov 6, 2024Jan 29, 2025May 7, 2025Jul 30, 2025Nov 5, 2025Jan 28, 2026Apr 29, 2026Jul 29, 2026Nov 3, 2026
EPS Estimate0.050.050.050.050.050.040.060.060.070.070.050.060.040.050.060.060.070.150.070.080.090.090.110.130.150.140.150.170.230.230.220.250.280.290.330.370.390.380.360.380.430.420.450.640.580.400.550.620.660.630.640.700.730.680.810.880.950.881.051.271.291.031.091.251.591.441.291.251.331.101.201.261.401.221.221.241.301.261.331.281.281.171.211.281.351.031.061.030.760.670.640.540.550.580.580.590.610.590.530.580.620.600.590.650.730.550.560.620.710.550.530.610.760.510.550.660.700.460.620.660.640.460.050.70
EPS Actual0.050.050.050.050.030.050.060.060.070.070.040.050.040.050.060.060.070.080.080.080.090.100.120.140.170.160.170.180.250.250.250.270.310.320.350.380.410.380.360.400.450.370.660.740.530.420.630.640.690.640.650.720.760.710.830.890.940.910.961.141.141.041.101.251.591.471.281.281.321.121.201.271.421.221.231.321.311.361.431.351.281.201.251.311.381.061.021.000.930.940.780.680.530.600.600.580.620.760.550.580.680.630.590.590.770.550.680.590.710.400.560.601.000.480.610.690.710.520.660.750.960.530.64-
Surprise0.00%0.00%0.00%0.00%-40.00%25.00%0.00%0.00%0.00%0.00%-20.00%-16.67%0.00%0.00%0.00%0.00%0.00%-46.67%14.29%0.00%0.00%11.11%9.09%7.69%13.33%14.29%13.33%5.88%8.70%8.70%13.64%8.00%10.71%10.34%6.06%2.70%5.13%0.00%0.00%5.26%4.65%-11.90%46.67%15.63%-8.62%5.00%14.55%3.23%4.55%1.59%1.56%2.86%4.11%4.41%2.47%1.14%-1.05%3.41%-8.57%-10.24%-11.63%0.97%0.92%0.00%0.00%2.08%-0.78%2.40%-0.75%1.82%0.00%0.79%1.43%0.00%0.82%6.45%0.77%7.94%7.52%5.47%0.00%2.56%3.31%2.34%2.22%2.91%-3.77%-2.91%22.37%40.30%21.88%25.93%-3.64%3.45%3.45%-1.69%1.64%28.81%3.77%0.00%9.68%5.00%0.00%-9.23%5.48%0.00%21.43%-4.84%0.00%-27.27%5.66%-1.64%31.58%-5.88%10.91%4.55%1.43%13.04%6.45%13.64%50.00%15.22%1180.00%-
Timing-------Pre-marketPre-marketPre-market-------------After-hours-Pre-marketAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap46.62B
Enterprise Value59.85B
Trailing P/E66.62
Forward P/E13.07
PEG Ratio1.02
Price / Sales2.69
Price / Book6.08
EPS0.60
Book Value6.65
Revenue (TTM)17.32B
Gross Profit (TTM)9.08B
EBITDA4.27B
Profit Margin4.08%
Operating Margin4.03%
Return on Equity9.69%
Return on Assets5.13%
Shares Outstanding1.17B
Shares Float1.09B
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 13 analystsTarget 47.58
  • Strong Buy
    8
  • Buy
    4
  • Hold
    1

Ownership Breakdown

Institutions
29.22%
Insiders
0.56%
Retail / Other
70.22%

Top Institutional Holders

  • BlackRock Inc
    63.89M5.48%
  • Harel Insurance Invests & Fin Srvcs Ltd
    48.14M4.13%
  • Phoenix Financial Ltd
    42.93M3.68%
  • WCM Investment Management
    41.32M3.54%
  • Clal Insurance Enterprises Holdings Ltd
    40.60M3.48%
  • MENORA MIVTACHIM HOLDINGS LIMITED
    39.85M3.42%
  • Migdal Insurance & Financial Holdings Ltd
    38.92M3.34%
  • NORGES BANK
    32.30M2.77%
  • FMR Inc
    30.26M2.59%
  • Exor Investments (UK) LLP
    20.21M1.73%
  • State Street Corp
    18.94M1.62%
  • Rubric Capital Management LP
    15.57M1.34%
  • Capital World Investors
    12.54M1.07%
  • Altshuler Shaham Ltd
    12.47M1.07%
  • Geode Capital Management, LLC
    11.61M1.00%
  • Meitav Dash Investments Ltd
    9.95M0.85%
  • Northern Trust Corp
    7.96M0.68%
  • Wellington Management Company LLP
    7.67M0.66%
  • JPMorgan Chase & Co
    6.98M0.60%
  • Morgan Stanley - Brokerage Accounts
    6.97M0.60%

Dividends

20174×
0.09Nov 27, 20170.09Aug 25, 20170.34Jun 1, 20170.34Feb 28, 2017
20164×
0.34Dec 1, 20160.34Aug 18, 20160.34May 20, 20160.34Feb 25, 2016
20154×
0.34Nov 13, 20150.34Aug 18, 20150.34May 15, 20150.34Feb 17, 2015
20144×
0.32Nov 13, 20140.35Aug 19, 20140.35May 16, 20140.34Feb 20, 2014
20134×
0.32Nov 20, 20130.32Aug 20, 20130.32May 16, 20130.31Feb 19, 2013
20124×
0.25Nov 15, 20120.25Aug 15, 20120.26May 21, 20120.26Feb 28, 2012

Stock Splits

  • Jul 1, 20042:1
  • Dec 6, 20022:1
  • Feb 23, 20002:1
  • Apr 14, 19932:1